Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Legend Biotech Analyst Ratings and Price Targets | NASDAQ:LEGN | Benzinga
Legend Biotech Corp has a consensus price target of $78.53 based on the ratings of 23 analysts. The high is $94 issued by Barclays on January 24, 2024. The low is $55 issued by Cantor Fitzgerald on May 14, 2025. The 3 most-recent analyst ratings were released by Truist Securities, Cantor Fitzgerald, and RBC Capital on May 14, 2025, May 14, 2025, and April 22, 2025, respectively. With an average price target of $70 between Truist Securities, Cantor Fitzgerald, and RBC Capital, there's an implied 151.98% upside for Legend Biotech Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Cantor Fitzgerald
RBC Capital
HC Wainwright & Co.
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Legend Biotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2025 | Buy Now | 155.58% | Truist Securities | Asthika Goonewardene46% | $88 → $71 | Maintains | Buy | Get Alert |
| 05/14/2025 | Buy Now | 97.98% | Cantor Fitzgerald | Rick Bienkowski32% | $55 → $55 | Reiterates | Overweight → Overweight | Get Alert |
| 04/22/2025 | Buy Now | 202.38% | RBC Capital | Brian Abrahams49% | $84 → $84 | Reiterates | Outperform → Outperform | Get Alert |
| 04/16/2025 | Buy Now | 169.98% | HC Wainwright & Co. | Mitchell Kapoor43% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2025 | Buy Now | 169.98% | HC Wainwright & Co. | Mitchell Kapoor43% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2025 | Buy Now | 187.98% | Morgan Stanley | Matthew Harrison33% | $82 → $80 | Maintains | Overweight | Get Alert |
| 03/12/2025 | Buy Now | — | Guggenheim | Michael Schmidt50% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/12/2025 | Buy Now | 169.98% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $75 | Maintains | Buy | Get Alert |
| 01/23/2025 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 01/21/2025 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | 180.78% | Piper Sandler | Edward Tenthoff50% | $78 → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 12/10/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 12/09/2024 | Buy Now | 198.78% | Cantor Fitzgerald | Rick Bienkowski32% | $83 → $83 | Reiterates | Overweight → Overweight | Get Alert |
| 12/09/2024 | Buy Now | 209.58% | RBC Capital | Leonid Timashev34% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 10/29/2024 | Buy Now | 209.58% | RBC Capital | Leonid Timashev34% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 10/08/2024 | Buy Now | 209.58% | Redburn Atlantic | Qize Ding4% | → $86 | Initiates | → Buy | Get Alert |
| 10/04/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 09/30/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 09/27/2024 | Buy Now | 209.58% | RBC Capital | Leonid Timashev34% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/28/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 209.58% | RBC Capital | Leonid Timashev34% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/12/2024 | Buy Now | 173.58% | Scotiabank | George Farmer38% | $70 → $76 | Maintains | Sector Outperform | Get Alert |
| 08/12/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 07/18/2024 | Buy Now | 151.98% | Scotiabank | George Farmer38% | $65 → $70 | Maintains | Sector Outperform | Get Alert |
| 07/18/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 07/15/2024 | Buy Now | 141.18% | TD Cowen | Yaron Werber16% | $71 → $67 | Maintains | Buy | Get Alert |
| 07/03/2024 | Buy Now | 223.97% | BMO Capital | Kostas Biliouris38% | $90 → $90 | Maintains | Outperform | Get Alert |
| 07/03/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | 209.58% | RBC Capital | Leonid Timashev34% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 06/17/2024 | Buy Now | 223.97% | Piper Sandler | Edward Tenthoff50% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 216.77% | Truist Securities | Asthika Goonewardene46% | → $88 | Initiates | → Buy | Get Alert |
| 06/06/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 162.78% | HC Wainwright & Co. | Mitchell Kapoor43% | $86 → $73 | Maintains | Buy | Get Alert |
| 05/23/2024 | Buy Now | 115.98% | Deutsche Bank | James Shin30% | → $60 | Initiates | → Buy | Get Alert |
| 05/14/2024 | Buy Now | 209.58% | RBC Capital | Leonid Timashev34% | $85 → $86 | Maintains | Outperform | Get Alert |
| 05/14/2024 | Buy Now | 209.58% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $86 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/23/2024 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2024 | Buy Now | 133.98% | Scotiabank | George Farmer38% | $65 → $65 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 04/16/2024 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | 195.18% | Cantor Fitzgerald | Rick Bienkowski32% | → $82 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | 191.58% | UBS | Ashwani Verma46% | $76 → $81 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | Buy Now | 209.58% | Raymond James | Sean McCutcheon11% | → $86 | Initiates | → Outperform | Get Alert |
| 03/12/2024 | Buy Now | 205.98% | RBC Capital | Leonid Timashev34% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/08/2024 | Buy Now | 205.98% | RBC Capital | Leonid Timashev34% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | Buy Now | 205.98% | RBC Capital | Leonid Timashev34% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 01/24/2024 | Buy Now | 238.37% | Barclays | Gena Wang49% | $93 → $94 | Maintains | Overweight | Get Alert |
| 12/22/2023 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 12/19/2023 | Buy Now | 133.98% | Scotiabank | George Farmer38% | → $65 | Initiates | → Sector Perform | Get Alert |
| 11/15/2023 | Buy Now | 213.17% | HC Wainwright & Co. | Mitchell Kapoor43% | $86 → $87 | Maintains | Buy | Get Alert |
| 10/18/2023 | Buy Now | 234.77% | Barclays | Gena Wang49% | $92 → $93 | Maintains | Overweight | Get Alert |
| 10/18/2023 | Buy Now | 209.58% | HC Wainwright & Co. | Mitchell Kapoor43% | $85 → $86 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 205.98% | HC Wainwright & Co. | Mitchell Kapoor43% | → $85 | Reiterates | Buy → Buy | Get Alert |
| 07/21/2023 | Buy Now | 205.98% | HC Wainwright & Co. | Mitchell Kapoor43% | $82 → $85 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | 231.17% | Barclays | Gena Wang49% | $90 → $92 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 205.98% | Morgan Stanley | Matthew Harrison33% | $65 → $85 | Maintains | Overweight | Get Alert |
| 06/16/2023 | Buy Now | 198.78% | RBC Capital | Leonid Timashev34% | → $83 | Reiterates | Outperform → Outperform | Get Alert |
| 06/13/2023 | Buy Now | 223.97% | BTIG | Justin Zelin40% | $85 → $90 | Maintains | Buy | Get Alert |
| 06/08/2023 | Buy Now | 195.18% | HC Wainwright & Co. | Mitchell Kapoor43% | → $82 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | Buy Now | 195.18% | HC Wainwright & Co. | Mitchell Kapoor43% | $77 → $82 | Maintains | Buy | Get Alert |
| 05/25/2023 | Buy Now | — | William Blair | Sami Corwin11% | — | Initiates | → Market Perform | Get Alert |
| 05/22/2023 | Buy Now | — | Daiwa Capital | Wilfred Yuen5% | — | Initiates | → Buy | Get Alert |
| 05/22/2023 | Buy Now | 177.18% | HC Wainwright & Co. | Mitchell Kapoor43% | → $77 | Reiterates | Buy → Buy | Get Alert |
| 05/19/2023 | Buy Now | 198.78% | RBC Capital | Leonid Timashev34% | $74 → $83 | Maintains | Outperform | Get Alert |
| 05/19/2023 | Buy Now | 223.97% | Barclays | Gena Wang49% | $65 → $90 | Maintains | Overweight | Get Alert |
| 04/25/2023 | Buy Now | 223.97% | BMO Capital | Kostas Biliouris38% | $79 → $90 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 177.18% | HC Wainwright & Co. | Mitchell Kapoor43% | $66 → $77 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 205.98% | BTIG | Justin Zelin40% | $75 → $85 | Maintains | Buy | Get Alert |
| 04/19/2023 | Buy Now | 173.58% | JP Morgan | Jessica Fye61% | $65 → $76 | Maintains | Overweight | Get Alert |
| 04/18/2023 | Buy Now | 137.58% | HC Wainwright & Co. | Mitchell Kapoor43% | → $66 | Reiterates | → Buy | Get Alert |
| 04/12/2023 | Buy Now | 137.58% | HC Wainwright & Co. | Mitchell Kapoor43% | → $66 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | Buy Now | 137.58% | HC Wainwright & Co. | Mitchell Kapoor43% | → $66 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | Buy Now | 137.58% | HC Wainwright & Co. | Mitchell Kapoor43% | → $66 | Initiates | → Buy | Get Alert |
| 03/24/2023 | Buy Now | 162.78% | RBC Capital | Leonid Timashev34% | → $73 | Initiates | → Outperform | Get Alert |
| 01/25/2023 | Buy Now | 133.98% | Barclays | Gena Wang49% | $53 → $65 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | 133.98% | Morgan Stanley | Matthew Harrison33% | $60 → $65 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 180.78% | Piper Sandler | Edward Tenthoff50% | $72 → $78 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | 133.98% | JP Morgan | Jessica Fye61% | $61 → $65 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | 137.58% | UBS | Ashwani Verma46% | → $66 | Initiates | → Buy | Get Alert |
| 11/02/2022 | Buy Now | — | Evercore ISI Group | Umer Raffat42% | — | Initiates | → Outperform | Get Alert |
| 11/01/2022 | Buy Now | — | Cowen & Co. | Yaron Werber16% | — | Initiates | → Outperform | Get Alert |
| 10/31/2022 | Buy Now | — | Guggenheim | Kelsey Goodwin30% | — | Initiates | → Neutral | Get Alert |
| 10/13/2022 | Buy Now | 115.98% | Morgan Stanley | Matthew Harrison33% | $63 → $60 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 126.78% | Morgan Stanley | Matthew Harrison33% | $55 → $63 | Maintains | Overweight | Get Alert |
| 06/17/2022 | Buy Now | 177.18% | BMO Capital | Kostas Biliouris38% | → $77 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Legend Biotech (LEGN) stock?
The latest price target for Legend Biotech (NASDAQ:LEGN) was reported by Truist Securities on May 14, 2025. The analyst firm set a price target for $71.00 expecting LEGN to rise to within 12 months (a possible 155.58% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Legend Biotech (LEGN)?
The latest analyst rating for Legend Biotech (NASDAQ:LEGN) was provided by Truist Securities, and Legend Biotech maintained their buy rating.
When was the last upgrade for Legend Biotech (LEGN)?
The last upgrade for Legend Biotech Corp happened on April 17, 2024 when Scotiabank raised their price target to $65. Scotiabank previously had a sector perform for Legend Biotech Corp.
When was the last downgrade for Legend Biotech (LEGN)?
There is no last downgrade for Legend Biotech.
When is the next analyst rating going to be posted or updated for Legend Biotech (LEGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Legend Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Legend Biotech was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
Is the Analyst Rating Legend Biotech (LEGN) correct?
While ratings are subjective and will change, the latest Legend Biotech (LEGN) rating was a maintained with a price target of $88.00 to $71.00. The current price Legend Biotech (LEGN) is trading at is $27.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
